Incidence and predictors of target vessel revascularization and clinical event rates of the sirolimus-eluting coronary stent (results from the prospective multicenter German Cypher Stent Registry)

American Journal of Cardiology

Volumn 95, Issue 11, 2005, Pages 1302-1308

  Zahn, Ralf ^a   Hamm, Christian W ^b   Schneider, Steffen ^b   Zeymer, Uwe ^b   Nienaber, Christoph A ^b   Richardt, Gert ^b   Kelm, Malte ^b   Levenson, Benny ^b   Bonzel, Tassilo ^b   Tebbe, Ulrich ^b   Sabin, Georg ^b   Senges, Jochen ^b  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RAPAMYCIN;

ADULT; AGED; ARTICLE; CLINICAL EXAMINATION; CLINICAL PRACTICE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DATA ANALYSIS; DEATH; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; FEMALE; FOLLOW UP; HEALTH CARE MANAGEMENT; HEART INFARCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; RESTENOSIS; REVASCULARIZATION; RISK ASSESSMENT; STROKE;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTI-BACTERIAL AGENTS; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY BYPASS; CORONARY RESTENOSIS; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; SIROLIMUS; STENTS;

EID: 21144454374     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.01.072     Document Type: Article

References (25)

1. R. Zahn, C.W. Hamm, U. Zeymer, S. Schneider, C.A. Nienaber, G. Richardt, M. Kelm, B. Levenson, T. Bonzel, U. Tebbe "Real life" use of sirolimus-eluting coronary stents in Germany: results from the prospective multi-centre German Cypher Registry Z Kardiol 93 2004 287 294
2. R. Zahn, C.W. Hamm, U. Zeymer, S. Schneider, C.A. Nienaber, G. Richardt, M. Kelm, B. Levenson, T. Bonzel, U. Tebbe Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany Results from the Prospective Multicenter German Cypher Registry Herz 29 2004 181 186
3. T.M. Bashore, E.R. Bates, P.B. Berger, D.A. Clark, J.T. Cusma, G.J. Dehmer, M.J. Kern, W.K. Laskey, M.P. O'Laughlin, S. Oesterle American College of Cardiology/Society for Cardiac Angiography and Interventions clinical expert consensus document on cardiac catheterization laboratory standards A report of the American College of Cardiology task force on clinical expert consensus documents J Am Coll Cardiol 37 2001 2170 2214
4. P.A. Lemos, A. Hoye, D. Goedhart, C.A. Arampatzis, F. Saia, W.J. van der Giessen, E. McFadden, G. Sianos, P.C. Smits, S.H. Hofma Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study Circulation 109 2004 1366 1370
5. J.W. Moses, M.B. Leon, J.J. Popma, P.J. Fitzgerald, D.R. Holmes, C. O'Shaughnessy, R.P. Caputo, D.J. Kereiakes, D.O. Williams, P.S. Teirstein Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323
6. J. Schofer, M. Schluter, A.H. Gershlick, W. Wijns, E. Garcia, E. Schampaert, G. Breithardt Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS) Lancet 362 2003 1093 1099
7. A. Colombo, J. Drzewiecki, A. Banning, E. Grube, K. Hauptmann, S. Silber, D. Dudek, S. Fort, F. Schiele, K. Zmudka Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions Circulation 108 2003 788 794
8. G.W. Stone, S.G. Ellis, D.A. Cox, J. Hermiller, C. O'Shaughnessy, J.T. Mann, M. Turco, R. Caputo, P. Bergin, J. Greenberg A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 2004 221 231
9. A. Kastrati, J. Mehilli, J. Dirschinger, F. Dotzer, H. Schuhlen, F.J. Neumann, M. Fleckenstein, C. Pfafferott, M. Seyfarth, A. Schömig Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial Circulation 103 2001 2816 2821
10. J. Pache, A. Kastrati, J. Mehilli, H. Schuhlen, F. Dotzer, J. Hausleiter, M. Fleckenstein, F.J. Neumann, U. Sattelberger, C. Schmitt Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial J Am Coll Cardiol 41 2003 1283 1288
11. P.A. Lemos, P.W. Serruys, R.T. van Domburg, F. Saia, C.A. Arampatzis, A. Hoye, M. Degertekin, K. Tanabe, J. Daemen, T.K. Liu Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world." The Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) Registry Circulation 109 2004 190 195
12. A. Kastrati, S. Elezi, J. Dirschinger, M. Hadamitzky, F.J. Neumann, A. Schömig Influence of lesion length on restenosis after coronary stent placement Am J Cardiol 83 1999 1617 1622
13. A. Kastrati, A. Schömig, S. Elezi, H. Schuhlen, J. Dirschinger, M. Hadamitzky, A. Wehinger, J. Hausleiter, H. Walter, F.J. Neumann Predictive factors of restenosis after coronary stent placement J Am Coll Cardiol 30 1997 1428 1436
14. C. Bauters, E. Hubert, A. Prat, K. Bougrimi, E. Van Belle, E.P. McFadden, P. Amouyel, J.M. Lablanche, M. Bertrand Predictors of restenosis after coronary stent implantation J Am Coll Cardiol 31 1998 1291 1298
15. P.W. Serruys, I.P. Kay, C. Disco, N.V. Deshpande, P.J. de Feyter Periprocedural quantitative coronary angiography after Palmaz-Schatz stent implantation predicts the restenosis rate at six months: results of a meta-analysis of the BElgian NEtherlands Stent study (BENESTENT) I, BENESTENT II Pilot, BENESTENT II and MUSIC trials Multicenter Ultrasound Stent In Coronaries J Am Coll Cardiol 34 1999 1067 1074
16. P.J. de Feyter, P. Kay, C. Disco, P.W. Serruys Reference chart derived from post-stent-implantation intravascular ultrasound predictors of 6-month expected restenosis on quantitative coronary angiography Circulation 100 1999 1777 1783
17. N. Mercado, E. Boersma, W. Wijns, B.J. Gersh, C.A. Morillo, V. de Volk, G.A. van Es, D.E. Grobbee, P.W. Serruys Clinical and quantitative coronary angiographic predictors of coronary restenosis: a comparative analysis from the balloon-to-stent era J Am Coll Cardiol 38 2001 645 652
18. S.H. Fenton, D.L. Fischman, M.P. Savage, R.A. Schatz, M.B. Leon, D.S. Baim, S.B. King, R.R. Heuser, R.C. Curry Jr, R.C. Rake Long-term angiographic and clinical outcome after implantation of balloon-expandable stents in aortocoronary saphenous vein grafts Am J Cardiol 74 1994 1187 1191
19. I.K. de Scheerder, B.H. Strauss, P.J. de Feyter, K.J. Beatt, L.H. Baur, W. Wijns, G.R. Heyndrix, H. Suryapranata, M. van den Brand, B. Buis Stenting of venous bypass grafts: a new treatment modality for patients who are poor candidates for reintervention Am Heart J 123 1992 1046 1054
20. M.P. Savage, J.S. Douglas Jr, D.L. Fischman, C.J. Pepine, S.B. King III, J.A. Werner, S.R. Bailey, P.A. Overlie, S.H. Fenton, J.A. Brinker Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts Saphenous Vein De Novo Trial Investigators N Engl J Med 337 1997 740 747
21. A. Hoye, P.A. Lemos, C.A. Arampatzis, F. Saia, K. Tanabe, M. Degertekin, S. Hofma, E. McFadden, G. Sianos, P.C. Smits Effectiveness of the sirolimus-eluting stent in the treatment of saphenous vein graft disease J Invasive Cardiol 16 2004 230 233
22. P.M. Ridker, P. Haughie Prospective studies of C-reactive protein as a risk factor for cardiovascular disease J Investig Med 46 1998 391 395
23. P.M. Ridker, N. Rifai, M.A. Pfeffer, F.M. Sacks, L.A. Moye, S. Goldman, G.C. Flaker, E. Braunwald Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels Cholesterol and Recurrent Events (CARE) Investigators Circulation 98 1998 839 844
24. P.M. Ridker Inflammation, infection, and cardiovascular risk: how good is the clinical evidence? Circulation 97 1998 1671 1674
25. M. Singh, B.J. Gersh, R.L. McClelland, K.K. Ho, J.T. Willerson, W.F. Penny, D.R. Holmes Jr Clinical and angiographic predictors of restenosis after percutaneous coronary intervention: insights from the Prevention of Restenosis With Tranilast and Its Outcomes (PRESTO) trial Circulation 109 2004 2727 2731